Progress in application of alveolar exhaled nitric oxide in pediatric lung diseases
10.3760/cma.j.issn.1673-4408.2022.04.014
- VernacularTitle:肺泡呼出气一氧化氮在儿童肺疾病中的应用进展
- Author:
Xuran ZHANG
1
;
Yingxue ZOU
Author Information
1. 天津市儿童医院(天津大学儿童医院)马场院区呼吸科 300134
- Keywords:
Children;
Exhaled nitric oxide;
Bronchial asthma;
Interstitial lung disease
- From:
International Journal of Pediatrics
2022;49(4):274-278
- CountryChina
- Language:Chinese
-
Abstract:
As a biomarker of airway inflammation, alveolar exhaled nitric oxide(CaNO), which represents small airway inflammation, is increasingly used in respiratory diseases.CaNO not only can be applied to children bronchial asthma severity evaluation, the selection of treatment and treatment effect of the dynamic monitoring, can also be applied to the early diagnosis of interstitial lung disease and assessment of the severity of lung damage for other diseases such as tuberculosis, pulmonary hypertension diagnosis.This paper reviews the diagnostic and therapeutic value of CaNO in pediatric respiratory diseases, and discusses the role of CaNO in the diagnosis and therapeutic evaluation in pediatric lung diseases.
